Cargando…

Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation

In this overview, we discuss the role of class II-associated invariant chain peptide (CLIP) in acute myeloid leukemia (AML), one of the few tumors expressing HLA class II. The clinical impact, function and regulation of CLIP expression on leukemic cells is addressed, indicating its potential as immu...

Descripción completa

Detalles Bibliográficos
Autores principales: van Luijn, Marvin M., Chamuleau, Martine E.D., Ossenkoppele, Gert J., van de Loosdrecht, Arjan A., Marieke van Ham, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376995/
https://www.ncbi.nlm.nih.gov/pubmed/22720245
http://dx.doi.org/10.4161/onci.1.2.18100
_version_ 1782235898674413568
author van Luijn, Marvin M.
Chamuleau, Martine E.D.
Ossenkoppele, Gert J.
van de Loosdrecht, Arjan A.
Marieke van Ham, S.
author_facet van Luijn, Marvin M.
Chamuleau, Martine E.D.
Ossenkoppele, Gert J.
van de Loosdrecht, Arjan A.
Marieke van Ham, S.
author_sort van Luijn, Marvin M.
collection PubMed
description In this overview, we discuss the role of class II-associated invariant chain peptide (CLIP) in acute myeloid leukemia (AML), one of the few tumors expressing HLA class II. The clinical impact, function and regulation of CLIP expression on leukemic cells is addressed, indicating its potential as immunotherapeutic target in AML.
format Online
Article
Text
id pubmed-3376995
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-33769952012-06-20 Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation van Luijn, Marvin M. Chamuleau, Martine E.D. Ossenkoppele, Gert J. van de Loosdrecht, Arjan A. Marieke van Ham, S. Oncoimmunology Author's View In this overview, we discuss the role of class II-associated invariant chain peptide (CLIP) in acute myeloid leukemia (AML), one of the few tumors expressing HLA class II. The clinical impact, function and regulation of CLIP expression on leukemic cells is addressed, indicating its potential as immunotherapeutic target in AML. Landes Bioscience 2012-03-01 /pmc/articles/PMC3376995/ /pubmed/22720245 http://dx.doi.org/10.4161/onci.1.2.18100 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
van Luijn, Marvin M.
Chamuleau, Martine E.D.
Ossenkoppele, Gert J.
van de Loosdrecht, Arjan A.
Marieke van Ham, S.
Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation
title Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation
title_full Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation
title_fullStr Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation
title_full_unstemmed Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation
title_short Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation
title_sort tumor immune escape in acute myeloid leukemia: class ii-associated invariant chain peptide expression as result of deficient antigen presentation
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376995/
https://www.ncbi.nlm.nih.gov/pubmed/22720245
http://dx.doi.org/10.4161/onci.1.2.18100
work_keys_str_mv AT vanluijnmarvinm tumorimmuneescapeinacutemyeloidleukemiaclassiiassociatedinvariantchainpeptideexpressionasresultofdeficientantigenpresentation
AT chamuleaumartineed tumorimmuneescapeinacutemyeloidleukemiaclassiiassociatedinvariantchainpeptideexpressionasresultofdeficientantigenpresentation
AT ossenkoppelegertj tumorimmuneescapeinacutemyeloidleukemiaclassiiassociatedinvariantchainpeptideexpressionasresultofdeficientantigenpresentation
AT vandeloosdrechtarjana tumorimmuneescapeinacutemyeloidleukemiaclassiiassociatedinvariantchainpeptideexpressionasresultofdeficientantigenpresentation
AT mariekevanhams tumorimmuneescapeinacutemyeloidleukemiaclassiiassociatedinvariantchainpeptideexpressionasresultofdeficientantigenpresentation